有蹄类动物相关的专利数据

序号	专利名	申请号	申请日	公开（公告）号	公开（公告）日	发明人
201	CRYOPRESERVING UNGULATE EMBRYOS	PCT/IB2016/001112	2016-07-13	WO2017009713A2	2017-01-19	SANCHES, Bruno, Valente
Technologies for cryopreserving ungulate embryos for implantation into recipient females are described.
202	Leg Socks for Horses	US12980715	2010-12-29	US20110154787A1	2011-06-30	Raymond Petterson
The present invention comprises a sock for use on the leg of a horse or ungulate, such as a cow, donkey or other hoofed animal. In the preferred embodiment the sock is tubular in shape having an upper opening and a lower opening. The sock is generally comprised of an upper cuff, main body and lower cuff. The upper cuff and main body are configured to frictionally engage creating a circumferential force on the leg of the horse such that the sock will not easily slip down on the leg of the horse. Expanded knit around the knee joint and fetlock joints allow for the free motion of those joints thus alleviating contrary forces that would normally and otherwise cause the sock to be pulled down by that motion. The lower cuff is configured to expand over said hoof of said ungulate and when over the hoof conform to or hug the small pastern.
203	TRANSGENIC UNGULATES EXPRESSING CTLA4-IG AND USES THEREOF	EP06824805	2006-08-09	EP1924686A4	2009-11-11	AYARES DAVID LEE

204	Expression of xenogeneic (human) immunoglobulin in cloned, transgenic ungulate	JP2005136675	2005-05-09	JP2005224250A	2005-08-25	ROBL JAMES M; GOLDSBY RICHARD A; FERGUSON STACY E; KUROIWA YOSHIMI; TOMIZUKA KAZUMA; ISHIDA ISAO
<P>PROBLEM TO BE SOLVED: To provide transgenic ungulates deceased in expression of its endogenous antibodies. <P>SOLUTION: The ungulates containing mutation decreasing expression of endogenous antibodies on a gene encoding the endogenous antibodies, or containing a promotor decreasing expression of endogenous antibodies by functionally bonding the promotor to a gene encoding the endogenous antibodies are provided. <P>COPYRIGHT: (C)2005,JPO&NCIPI
205	Food and the method of extracting the same from colostrum and milk	US276230	1981-06-22	US4402938A	1983-09-06	Collins Mary E.; Robert A. Collins
This invention provides a new and useful food factor for use as a nutritional supplement for animals, which product comprises whey obtained from colostrum and milk as it comes from selected cows or other ungulates, and containing an active fraction having a molecular weight on the order of 1200 or less.
206	SINGLE DOSE RECOMBINANT BOVINE FSH AFTER FOLLICULAR SYNCHRONISATION	US14443193	2013-11-15	US20150335713A1	2015-11-26	ALEXANDRE SOUZA; NAOMI ISAKA; AUDE CARRIE; DOMINIQUE THIBAUD
The present invention relates to methods and compositions for increasing reproduction performance in non-human mammals using a biologically active recombinant Follicle Stimulating Hormone (rFSH). The invention also relates to methods for increasing ovulation or embryo production or pregnancies in non-human mammal using rFSH. The invention may be used in particular in ungulates such as bovine or equine.
207	Leg Socks for Horses	US14922702	2015-10-26	US20160286759A1	2016-10-06	Raymond Petterson
The present invention comprises a sock for use on the leg of a horse or ungulate, such as a cow, donkey or other hoofed animal. In the preferred embodiment the sock is tubular in shape having an upper opening and a lower opening. The sock is generally comprised of an upper cuff, main body and lower cuff. The upper cuff and main body are configured to frictionally engage creating a circumferential force on the leg of the horse such that the sock will not easily slip down on the leg of the horse. Expanded knit around the knee joint and fetlock joints allow for the free motion of those joints thus alleviating contrary forces that would normally and otherwise cause the sock to be pulled down by that motion. The lower cuff is configured to expand over said hoof of said ungulate and when over the hoof conform to or hug the small pastern.
208	TRANSGENIC UNGULATES EXPRESSING CTLA4-IG AND USES THEREOF	EP16181101.3	2006-08-09	EP3138403A1	2017-03-08	AYARES, David Lee
The present invention provides ungulates, including pigs, expressing CTLA4-Ig, as well as tissue, organs, cells and cell lines derived from such animals. Such animals, tissues, organs and cells can be used in research and medical therapy, including xenotransplantation, and nucleic acid constructs and vectors useful therein.
209	Compositions and methods for increasing reproduction performance in non human mammals using alpha-beta-linked follicle stimulating hormone	EP12306428.9	2012-11-16	EP2732824A1	2014-05-21	Souza, Alexandre; Isaka, Naomi; Carrie, Aude; Thibaud, Dominique
The present invention relates to methods and compositions for increasing reproduction performance in non-human mammals using a biologically active recombinant Follicle Stimulating Hormone (rFSH). The invention also relates to methods for increasing ovulation or embryo production or pregnancies in non-human mammal using rFSH. The invention may be used in particular in ungulates such as bovine or equine.
210	Bio-screening methods and biomaterial thereof	US09865251	2001-05-25	US20020177225A1	2002-11-28	Rodolfo C. Quijano; Hosheng Tu
This invention discloses a bio-screening method for preparing a biomaterial adapted for medical device use, the method comprising chemically treating tissue of biological origin from a mammal. The mammal of the present invention comprises a perissodactylous ungulate that is naturally absent of foot-and-mouth disease and/or transmissible spongiform encephalopathy disease.
211	Embryonic germ cells, method for making same, and using the cells to produce a chimeric porcine	US09627919	2000-07-28	US06545199B1	2003-04-08	Gary B. Anderson; Hosup Shim
Primordial germ cells are extracted from post blastocyst embryos of an ungulate such as extracting primordial germ cells from the gonadal ridges of 25-day porcine embryos or 34-40 day bovine embryos. The primordial germ cells are cultured in long term culture (over 30 days) resulting in cells which resemble embryonic stem cells in morphology and with respect to maintaining pluripotency. The cells obtained can be maintained for several months in culture and can be genetically manipulated using homologous recombination technology in order to insert desired genetic material into the genetic compliment of the cell at a desired location. The genetically manipulated cell can be inserted into a blastocyst obtained from the same species of animal as the cell was derived in order to produce a chimeric ungulate which ungulate may, via its genetic engineering, produce desired pharmaceutical products.
212	Method of producing antibody-fortified dry whey	US259735	1988-10-19	US5017372A	1991-05-21	Donald H. Hastings
A method of producing a dry whey protein powder fortified with naturally occurring polyclonal antibody IgG to preselected infectious intestinal disease antigens, primarily diarrhea-causing enterotoxigenic Escherichia coli bacteria bearing colonization factor antigens (CFA) I or II and heat labile toxins. The product is made by first immunizing a pregnant ungulate, such as a cow, by administration of antigens of the preselected disease. After parturition the milk from the ungulate is collected and maintained in its natural state. The milk is subjected to a standard cheese-making process which produces coagulated casein and whey. The antibody IgG is carried into the whey, which is concentrated and dried. The resulting dried protein powder contains the antibody. The product may be administered orally to living beings, both humans and other animals, to prevent contraction of the preselected disease and to treat bodies exposed to the disease.
213	TEXAS GAME DRAW	US11365312	2006-08-28	US20080050411A1	2008-02-28	Jonathan David Rudd
The present invention is a game attractant comprised of a mixture of rice bran, wheat bran and dried molasses to attract the attention of ungulates and avian fauna. By the incorporation of these three ingredients, the nutritional and vitamin value is elevated above the natural diet of the fauna. Therefore once expelled in pyramid form upon the intended-sight, the animals are attracted to the richness of this mix.
214	Vaccine against papillomatous digital dermatitis (PDD)	US09516043	2000-03-01	US20030086947A1	2003-05-08	Richard L. Walker; Deryck H. Read; David W. Hird; Rance B. Lefebvre; Steven L. Berry; James S. Cullor; Hank M. Lefler
This invention relates to the diagnosis and prevention of ungulate diseases caused by the spirochete bacteria Treponema. The invention specifically relates to isolated cultures of this spirochete and isolated nucleic acids and proteins.
215	Vaccine against papillomatous digital dermatitis (PDD)	US08943571	1997-10-03	US06287575B1	2001-09-11	Richard L. Walker; Deryck H. Read; David W. Hird; Rance B. Lefebvre; Steven L. Berry; James S. Cullor; Hank M. Lefler
This invention relates to the diagnosis and prevention of ungulate diseases caused by the spirochete bacteria Treponema. The invention specifically relates to isolated cultures of this spirochete and isolated nucleic acids and proteins.
216	HOOF REPAIR COATING	US15231743	2016-08-08	US20170037275A1	2017-02-09	ALLEN D. JOHNSTON
The present invention relates to curable coatings for treatment and repair of the ungulate hoof. These coatings are very easy to apply to the hoof of the animal, and cure to a tack-free hard coating as the animal walks around in direct sunlight or upon short exposure to ultraviolet light. Regular treatment of the coating to the hoof prevents hoof cracks in the long run and improves the health of the animal.
217	Production of ungulates, preferably bovines that produce human immunoglobulins	US11011711	2004-12-14	US20050183145A1	2005-08-18	Richard Goldsby; James Robl; Barbara Osborne
The present invention relates to a method of producing an ungulate having both copies of the IgM heavy chain (mu) rag-1 and/or rag-2 gene eliminated from its genome. Animals which have IgM, rag-1 and/or rag-2 eliminated from their genome are unable to conduct the gene rearrangements that are necessary to generate the antigen receptors of B or T lymphocytes, and therefore will not develop native B or T cells. Because they are unable to produce B and T lymphocytes, these IgM, rag-1 or rag-2 ungulates cannot reject human hematopoietic stem cell preparations, and B and T lymphocytes which develop therefrom. Therefore, the present invention also involves injecting into IgM, rag-1 and/or rag-2 deficient ungulates, in utero or shortly after birth, human B and T lymphocytes whose immune systems produce human immunoglobulin that can be processed for therapeutic uses in humans.
218	AKUSTISCHE ERMITTLUNG DER GANGART EINES HUFTIERES	PCT/DE2013/000184	2013-04-10	WO2013152754A1	2013-10-17	SCHÖN, Peter-Christian; WENDLAND, Kurt
Die Gangart von Huftieren, insbesondere landwirtschaftlichen Nutztieren, wird akustisch ermittelt, so dass beispielsweise Huferkrankungen im Frühstadium erkannt werden können. Eine gegebene Gangart von Huftieren, speziell landwirtschaftlichen Nutztieren wird bestimmt, um unnatürliche Weisen einer Gangart zu erkennen. Dazu werden die Auftrittgeräusche eines Nutztieres/Huftieres (1) durch (einen) Schallsensor/en (5) in einem Frequenzbereich von mindestens 20 Hz bis 5 kHz erfasst. Die analogen Ausgangssignale werden dann an eine Signalaufbereitungseinheit (7) weitergeleitet und von dieser digitalisiert. Von der Signalaufbereitungseinheit (7) werden mindestens die spezifischen Parameter Zeitablauf und Verlauf der Auftritte, Frequenzspektrum und deren Verlauf, sowie das Schallpegelspektrum in mindestens einen Parametervektor konvertiert. Dieser/diese wird an eine Auswertungseinheit (8) weitergeleitet und dort klassifiziert und der Grad der Ähnlichkeit mit zuvor aufgenommenen Parametervektoren bestimmt.
219	METHOD OF HOOF TRIMMING OF UNGULATES BY A LIQUID JET AND A VETERINARY TRIMMING ASSEMBLY	PCT/SK2014/050024	2014-12-08	WO2015088454A1	2015-06-18	KRAJNÝ, Zdenko, Ing.
A method of hoof trimming of ungulates by a liquid jet, characterised in a sequence of steps: • stabilizing of the ungulate's hoof in a clamping device and/or a cage; • cleaning the ungulate's hoof and claw by a pressure liquid; • and preferably also in physical diagnostics of the hoof and the claw with locating of the borderline between the hoof and claw, • outlining of the cutting plane in the borderline area between the hoof and the claw; • separating the claw from the hoof by means of a liquid jet of a veterinary trimming assembly in an air or liquid environment along the cutting plane by the action of the pressure liquid jet with the operating pressure of 1 ₂0 to 250 MPa and the pressure liquid flow rate of 4 to 15 l/min with the pressure liquid jet feed rate of 10 to 220 mm/min, wherein the thickness of the pressure liquid jet is 0.5 to 1.0 mm. The pressure liquid is water, or possibly water with an added abrasive and/or a disinfectant and/or a medicinal agent.
220	Production of ungulates, preferably bovines that produce human immunoglobulins	US10072556	2002-02-07	US20030056237A1	2003-03-20	Richard A. Goldsby; James M. Robl
The present invention relates to a method of producing an ungulate having both copies of the IgM heavy chain (mu) rag-1 and/or rag-2 gene eliminated from its genome. Animals which have IgM, rag-1 and/or rag-2 eliminated from their genome are unable to conduct the gene rearrangements that are necessary to generate the antigen receptors of B or T lymphocytes, and therefore will not develop native B or T cells. Because they are unable to produce B and T lymphocytes, these IgM, rag-1 or rag-2 ungulates cannot reject human hematopoietic stem cell preparations, and B and T lymphocytes which develop therefrom. Therefore, the present invention also involves injecting into IgM, rag-1 and/or rag-2 deficient ungulates, in utero or shortly after birth, human B and T lymphocytes whose immune systems produce human immunoglobulin that can be processed for therapeutic uses in humans.

6 7 8 9 10 11 12 13 14 15

IPRDB

热门服务

关于我们

友情链接

联系方式